Abstract
Thirty-one chronic perennial asthmatics aged from 2½ to 16 years were treated with beclomethasone dipropionate pressurized aerosols for up to 20 months. Of these, 16 patients dependent on oral corticosteroid or corticotrophin for up to 11 years were successfully transferred to this treatment, with one exception. Steroid withdrawal symptoms were slight. Loss of weight, disappearance of Cushingoid features, and resumption of growth indicated lack of systemic side effects. Fifteen others inadequately controlled on bronchodilators or disodium cromoglycate, were also effectively treated, and no clinical evidence of adrenal suppression was noted.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown H. M., Storey G., George W. H. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. Br Med J. 1972 Mar 4;1(5800):585–590. doi: 10.1136/bmj.1.5800.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choo-Kang Y. F., Cooper E. J., Tribe A. E., Grant I. W. Beclomethasone dipropionate by inhalation in the treatment of airways obstruction. Br J Dis Chest. 1972 Apr;66(2):101–106. [PubMed] [Google Scholar]
- Lal S., Harris D. M., Bhalla K. K., Singhal S. N., Butler A. G. Comparison of beclomethasone dipropionate aerosol and prednisolone in reversible airways obstruction. Br Med J. 1972 Aug 5;3(5822):314–317. doi: 10.1136/bmj.3.5822.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SANERKIN N. G., EVANS D. M. THE SPUTUM IN BRONCHIAL ASTHMA: PATHOGNOMONIC PATTERNS. J Pathol Bacteriol. 1965 Apr;89:535–541. [PubMed] [Google Scholar]